Reports for APO-MONTELUKAST
Brand name
APO-MONTELUKAST
Company Name
APOTEX INC
|
Drug Identification Number
02377616 |
Ingredients
MONTELUKAST |
Ingredient Strength
5 MG |
ATC Code
R03DC |
ATC Descriptor
OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
APO-MONTELUKAST | 30 BLS | Resolved | 2018-08-09 | 2018-10-16 | 57792 |
APO-MONTELUKAST | 30 BLS | Resolved | 2018-10-11 | 2018-10-16 | 63793 |
APO-MONTELUKAST | 30 BLS | Resolved | 2019-01-15 | 2020-04-07 | 72357 |
APO-MONTELUKAST | 30 BLS | Resolved | 2022-09-09 | 2022-12-05 | 169054 |
APO-MONTELUKAST | 30 BLS | Resolved | 2023-09-07 | 2023-10-15 | 203825 |
Showing 1 to 5 of 5
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0